C-Path’s CDRC Meeting Highlights the Importance of Drug Repurposing The Critical Path Institute’s CURE Drug Repurposing Collaboratory and FDA hosted their annual meeting April 18-20 to bring toget
April 26, 2023 C-Path Europe: A Global Vision of Success TUCSON, Ariz. and AMSTERDAM, April 26, 2023 — As an organization that generates regulatory-endorsed solutions and methodologies
June 8, 2023 View Now: GUIDs and De-Identification Tools for Rare Diseases C-Path’s Rare Disease Cures Accelerator-Data and Analytics Platform is pleased to present this new webinar, GUIDs and De-Identi
April 24, 2023 Leveraging Biolink as a “Rosetta Stone” Between C-Path and EJP-RD Semantic Models Provides Emergent Interoperability
Rare Disease COA Consortium Announces Publication of Open Access Article C-Path’s Rare Disease COA Consortium is pleased to announce that “Approaches to the Assessment of Clinical Benefit of Treatmen
April 20, 2023 CRDSA Secondary Use Data Sharing Webinar Please join the Clinical Research Data Sharing Alliance on Thursday, April 20, for “Secondary Use Data: What do R
March 15, 2023 Critical Path for Rare Neurodegenerative Diseases (CP-RND): An Introduction to the Patient Community Thank you for your interest in the recent webinar, Critical Path for Rare Neurodegenerative Diseases (CP-RND): An Introduction...
March 29, 2023 C-Path Appoints Key Scientific Leaders to Executive Roles Critical Path Institute (C-Path) announced today the appointment of three accomplished leaders to key executive roles within the..